Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

In vivo biotransformations of indium phosphide quantum dots revealed by X-ray micro-spectroscopy.

Veronesi G, Moros M, Castillo-Michel HA, Mattera L, Onorato G, Wegner KDD, Ling WL, Reiss P, Tortiglione C.

ACS Appl Mater Interfaces. 2019 Sep 9. doi: 10.1021/acsami.9b15433. [Epub ahead of print]

PMID:
31496235
2.

Psychosomatic and vasomotor symptom changes during transition to menopause.

Augoulea A, Moros M, Lykeridou A, Kaparos G, Lyberi R, Panoulis K.

Prz Menopauzalny. 2019 Jun;18(2):110-115. doi: 10.5114/pm.2019.86835. Epub 2019 Jun 28. Review.

3.

Synthesis, functionalization and properties of uniform europium-doped sodium lanthanum tungstate and molybdate (NaLa(XO4)2, X = Mo,W) probes for luminescent and X-ray computed tomography bioimaging.

Laguna M, Nuñez NO, Becerro AI, Lozano G, Moros M, de la Fuente JM, Corral A, Balcerzyk M, Ocaña M.

J Colloid Interface Sci. 2019 Oct 15;554:520-530. doi: 10.1016/j.jcis.2019.07.031. Epub 2019 Jul 13.

PMID:
31330425
4.

An efficient approach to eliminate steryl ethers and miscellaneous esters/ketones for gas chromatographic analysis of alkenones and alkenoates.

Wang L, Longo WM, Dillon JT, Zhao J, Zheng Y, Moros M, Huang Y.

J Chromatogr A. 2019 Jul 5;1596:175-182. doi: 10.1016/j.chroma.2019.02.064. Epub 2019 Mar 13.

PMID:
30898380
5.

An Integrated Multilevel Analysis Profiling Biosafety and Toxicity Induced by Indium- and Cadmium-Based Quantum Dots in Vivo.

Allocca M, Mattera L, Bauduin A, Miedziak B, Moros M, De Trizio L, Tino A, Reiss P, Ambrosone A, Tortiglione C.

Environ Sci Technol. 2019 Apr 2;53(7):3938-3947. doi: 10.1021/acs.est.9b00373. Epub 2019 Mar 13.

PMID:
30821457
6.

Aggregation effects on the magnetic properties of iron oxide colloids.

Gutiérrez L, de la Cueva L, Moros M, Mazarío E, de Bernardo S, de la Fuente JM, Morales MP, Salas G.

Nanotechnology. 2019 Mar 15;30(11):112001. doi: 10.1088/1361-6528/aafbff. Epub 2019 Jan 4.

PMID:
30609414
7.

DNA-Coated Gold Nanoparticles for the Detection of mRNA in Live Hydra Vulgaris Animals.

Moros M, Kyriazi ME, El-Sagheer AH, Brown T, Tortiglione C, Kanaras AG.

ACS Appl Mater Interfaces. 2019 Apr 17;11(15):13905-13911. doi: 10.1021/acsami.8b17846. Epub 2018 Dec 11.

PMID:
30525369
8.

TotShots: An Innovative Pediatric Free Clinic Providing High Patient Satisfaction to the Underserved.

LaGrandeur J, Moros M, Dobrick J, Rahimian R, Siyahian A, Tomlinson E, Gordon P.

Fam Med. 2018 Nov;50(10):779-781. doi: 10.22454/FamMed.2018.678901.

PMID:
30428108
9.

Biocompatibility assessment of up-and down-converting nanoparticles: implications of interferences with in vitro assays.

Pem B, González-Mancebo D, Moros M, Ocaña M, Becerro AI, Pavičić I, Selmani A, Babič M, Horák D, Vinković Vrček I.

Methods Appl Fluoresc. 2018 Nov 6;7(1):014001. doi: 10.1088/2050-6120/aae9c8.

PMID:
30398160
10.

Triggering antitumoural drug release and gene expression by magnetic hyperthermia.

Moros M, Idiago-López J, Asín L, Moreno-Antolín E, Beola L, Grazú V, Fratila RM, Gutiérrez L, de la Fuente JM.

Adv Drug Deliv Rev. 2019 Jan 1;138:326-343. doi: 10.1016/j.addr.2018.10.004. Epub 2018 Oct 17. Review.

PMID:
30339825
11.

Fabrication of photothermally active poly(vinyl alcohol) films with gold nanostars for antibacterial applications.

Borzenkov M, Moros M, Tortiglione C, Bertoldi S, Contessi N, Faré S, Taglietti A, D'Agostino A, Pallavicini P, Collini M, Chirico G.

Beilstein J Nanotechnol. 2018 Jul 23;9:2040-2048. doi: 10.3762/bjnano.9.193. eCollection 2018.

12.

Nanoparticles engineered to bind cellular motors for efficient delivery.

Dalmau-Mena I, Del Pino P, Pelaz B, Cuesta-Geijo MÁ, Galindo I, Moros M, de la Fuente JM, Alonso C.

J Nanobiotechnology. 2018 Mar 30;16(1):33. doi: 10.1186/s12951-018-0354-1.

13.

Effect of Surface Chemistry and Associated Protein Corona on the Long-Term Biodegradation of Iron Oxide Nanoparticles In Vivo.

Stepien G, Moros M, Pérez-Hernández M, Monge M, Gutiérrez L, Fratila RM, Las Heras M, Menao Guillén S, Puente Lanzarote JJ, Solans C, Pardo J, de la Fuente JM.

ACS Appl Mater Interfaces. 2018 Feb 7;10(5):4548-4560. doi: 10.1021/acsami.7b18648. Epub 2018 Jan 23.

PMID:
29328627
14.

Climate induced human demographic and cultural change in northern Europe during the mid-Holocene.

Warden L, Moros M, Neumann T, Shennan S, Timpson A, Manning K, Sollai M, Wacker L, Perner K, Häusler K, Leipe T, Zillén L, Kotilainen A, Jansen E, Schneider RR, Oeberst R, Arz H, Sinninghe Damsté JS.

Sci Rep. 2017 Nov 10;7(1):15251. doi: 10.1038/s41598-017-14353-5.

15.

Multiparametric analysis of anti-proliferative and apoptotic effects of gold nanoprisms on mouse and human primary and transformed cells, biodistribution and toxicity in vivo.

Pérez-Hernández M, Moros M, Stepien G, Del Pino P, Menao S, de Las Heras M, Arias M, Mitchell SG, Pelaz B, Gálvez EM, de la Fuente JM, Pardo J.

Part Fibre Toxicol. 2017 Oct 26;14(1):41. doi: 10.1186/s12989-017-0222-4.

16.

Size differences of Arctic marine protists between two climate periods-using the paleoecological record to assess the importance of within-species trait variation.

Mousing EA, Ribeiro S, Chisholm C, Kuijpers A, Moros M, Ellegaard M.

Ecol Evol. 2016 Nov 27;7(1):3-13. doi: 10.1002/ece3.2592. eCollection 2017 Jan.

17.

Gold nanoprism-nanorod face off: comparing the heating efficiency, cellular internalization and thermoablation capacity.

Alfranca G, Artiga Á, Stepien G, Moros M, Mitchell SG, de la Fuente JM.

Nanomedicine (Lond). 2016 Nov;11(22):2903-2916. Epub 2016 Oct 27.

PMID:
27785974
18.

Diagnostic Accuracy of the FIGO and the 5-Tier Fetal Heart Rate Classification Systems in the Detection of Neonatal Acidemia.

Martí Gamboa S, Giménez OR, Mancho JP, Moros ML, Sada JR, Mateo SC.

Am J Perinatol. 2017 Apr;34(5):508-514. doi: 10.1055/s-0036-1593810. Epub 2016 Oct 25.

PMID:
27780275
19.

Controlling Properties and Cytotoxicity of Chitosan Nanocapsules by Chemical Grafting.

De Matteis L, Alleva M, Serrano-Sevilla I, García-Embid S, Stepien G, Moros M, de la Fuente JM.

Mar Drugs. 2016 Sep 30;14(10). pii: E175.

20.

Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a(1-21)NH2 as a reliable strategy for antipseudomonal drugs.

Casciaro B, Moros M, Rivera-Fernández S, Bellelli A, de la Fuente JM, Mangoni ML.

Acta Biomater. 2017 Jan 1;47:170-181. doi: 10.1016/j.actbio.2016.09.041. Epub 2016 Sep 29.

PMID:
27693686
21.

A Lectin Purified from Blood Red Bracket Mushroom, Pycnoporus sanguineus (Agaricomycetidae), Mycelium Displayed Affinity Toward Bovine Transferrin.

Albores S, Moros M, Cerdeiras MP, de la Fuente JM, Grazu V, Fraguas LF.

Int J Med Mushrooms. 2016;18(1):67-74. doi: 10.1615/IntJMedMushrooms.v18.i1.80.

PMID:
27279446
22.

Greek-origin royal jelly improves the lipid profile of postmenopausal women.

Lambrinoudaki I, Augoulea A, Rizos D, Politi M, Tsoltos N, Moros M, Chinou I, Graikou K, Kouskouni E, Kambani S, Panoulis K, Moutsatsou P.

Gynecol Endocrinol. 2016 Oct;32(10):835-839. Epub 2016 May 26.

PMID:
27227757
23.
24.

Magnetic-Responsive Release Controlled by Hot Spot Effect.

Guisasola E, Baeza A, Talelli M, Arcos D, Moros M, de la Fuente JM, Vallet-Regí M.

Langmuir. 2015 Nov 24;31(46):12777-82. doi: 10.1021/acs.langmuir.5b03470. Epub 2015 Nov 12.

PMID:
26536300
25.

Recent advances in biosensing using magnetic glyconanoparticles.

Fratila RM, Moros M, de la Fuente JM.

Anal Bioanal Chem. 2016 Mar;408(7):1783-803. doi: 10.1007/s00216-015-8953-2. Epub 2015 Aug 18. Review.

PMID:
26282487
26.

Deciphering intracellular events triggered by mild magnetic hyperthermia in vitro and in vivo.

Moros M, Ambrosone A, Stepien G, Fabozzi F, Marchesano V, Castaldi A, Tino A, de la Fuente JM, Tortiglione C.

Nanomedicine (Lond). 2015 Jul;10(14):2167-83. doi: 10.2217/nnm.15.70. Epub 2015 May 11.

27.

Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier.

Prades R, Oller-Salvia B, Schwarzmaier SM, Selva J, Moros M, Balbi M, Grazú V, de La Fuente JM, Egea G, Plesnila N, Teixidó M, Giralt E.

Angew Chem Int Ed Engl. 2015 Mar 23;54(13):3967-72. doi: 10.1002/anie.201411408. Epub 2015 Feb 4.

PMID:
25650865
28.

Citrate-capped gold nanoparticles for the label-free detection of ubiquitin C-terminal hydrolase-1.

Agarwal S, Mishra P, Shivange G, Kodipelli N, Moros M, de la Fuente JM, Anindya R.

Analyst. 2015 Feb 21;140(4):1166-73. doi: 10.1039/c4an01935k.

PMID:
25516911
29.

Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms.

Pérez-Hernández M, Del Pino P, Mitchell SG, Moros M, Stepien G, Pelaz B, Parak WJ, Gálvez EM, Pardo J, de la Fuente JM.

ACS Nano. 2015 Jan 27;9(1):52-61. doi: 10.1021/nn505468v. Epub 2014 Dec 17.

PMID:
25493329
30.

Nanoparticle-mediated monitoring of carbohydrate-lectin interactions using Transient Magnetic Birefringence.

Köber M, Moros M, Franco Fraguas L, Grazú V, de la Fuente JM, Luna M, Briones F.

Anal Chem. 2014 Dec 16;86(24):12159-65. doi: 10.1021/ac503122y. Epub 2014 Dec 5.

PMID:
25417550
31.

A promising road with challenges: where are gold nanoparticles in translational research?

Bao C, Conde J, Polo E, del Pino P, Moros M, Baptista PV, Grazu V, Cui D, de la Fuente JM.

Nanomedicine (Lond). 2014 Oct;9(15):2353-70. doi: 10.2217/nnm.14.155.

PMID:
25413854
32.

Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine.

Conde J, Dias JT, Grazú V, Moros M, Baptista PV, de la Fuente JM.

Front Chem. 2014 Jul 15;2:48. doi: 10.3389/fchem.2014.00048. eCollection 2014. Review.

33.

Echoes from the past: a healthy Baltic Sea requires more effort.

Kotilainen AT, Arppe L, Dobosz S, Jansen E, Kabel K, Karhu J, Kotilainen MM, Kuijpers A, Lougheed BC, Meier HE, Moros M, Neumann T, Porsche C, Poulsen N, Rasmussen P, Ribeiro S, Risebrobakken B, Ryabchuk D, Schimanke S, Snowball I, Spiridonov M, Virtasalo JJ, Weckström K, Witkowski A, Zhamoida V.

Ambio. 2014 Feb;43(1):60-8. doi: 10.1007/s13280-013-0477-4.

34.

DNA as a molecular local thermal probe for the analysis of magnetic hyperthermia.

Dias JT, Moros M, Del Pino P, Rivera S, Grazú V, de la Fuente JM.

Angew Chem Int Ed Engl. 2013 Oct 25;52(44):11526-9. doi: 10.1002/anie.201305835. Epub 2013 Sep 23.

PMID:
24115553
35.

Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC).

Andrés R, Pajares I, Balmaña J, Llort G, Ramón Y Cajal T, Chirivella I, Aguirre E, Robles L, Lastra E, Pérez-Segura P, Bosch N, Yagüe C, Lerma E, Godino J, Miramar MD, Moros M, Astier P, Saez B, Vidal MJ, Arcusa A, Ramón y Cajal S, Calvo MT, Tres A.

Clin Transl Oncol. 2014 Mar;16(3):280-4. doi: 10.1007/s12094-013-1070-9. Epub 2013 Aug 27.

PMID:
23982851
36.

Tips for the functionalization of nanoparticles with antibodies.

Polo E, Puertas S, Moros M, Batalla P, Guisán JM, de la Fuente JM, Grazú V.

Methods Mol Biol. 2013;1051:149-63. doi: 10.1007/978-1-62703-550-7_11.

PMID:
23934804
37.

The fate of nanocarriers as nanomedicines in vivo: important considerations and biological barriers to overcome.

Moros M, Mitchell SG, Grazú V, de la Fuente JM.

Curr Med Chem. 2013;20(22):2759-78. Review.

PMID:
23627938
38.

Application of magnetically induced hyperthermia in the model protozoan Crithidia fasciculata as a potential therapy against parasitic infections.

Grazú V, Silber AM, Moros M, Asín L, Torres TE, Marquina C, Ibarra MR, Goya GF.

Int J Nanomedicine. 2012;7:5351-60. doi: 10.2147/IJN.S35510. Epub 2012 Oct 8.

39.

Functionalized Fe₃O₄@Au superparamagnetic nanoparticles: in vitro bioactivity.

Salado J, Insausti M, Lezama L, Gil de Muro I, Moros M, Pelaz B, Grazu V, de la Fuente JM, Rojo T.

Nanotechnology. 2012 Aug 10;23(31):315102. doi: 10.1088/0957-4484/23/31/315102.

PMID:
22802157
40.

Transient magnetic birefringence for determining magnetic nanoparticle diameters in dense, highly light scattering media.

Köber M, Moros M, Grazú V, de la Fuente JM, Luna M, Briones F.

Nanotechnology. 2012 Apr 20;23(15):155501. doi: 10.1088/0957-4484/23/15/155501. Epub 2012 Mar 28.

PMID:
22456180
41.

Phrynoderma: a rare dermatologic complication of bariatric surgery.

Ocón J, Cabrejas C, Altemir J, Moros M.

JPEN J Parenter Enteral Nutr. 2012 May;36(3):361-4. doi: 10.1177/0148607111422067. Epub 2012 Jan 23.

PMID:
22269897
42.

Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake.

Moros M, Hernáez B, Garet E, Dias JT, Sáez B, Grazú V, González-Fernández A, Alonso C, de la Fuente JM.

ACS Nano. 2012 Feb 28;6(2):1565-77. doi: 10.1021/nn204543c. Epub 2012 Jan 9.

PMID:
22214244
43.

Specific peptides as alternative to antibody ligands for biomagnetic separation of Clostridium tyrobutyricum spores.

Lavilla M, Moros M, Puertas S, Grazú V, Pérez MD, Calvo M, de la Fuente JM, Sánchez L.

Anal Bioanal Chem. 2012 Apr;402(10):3219-26. doi: 10.1007/s00216-011-5621-z. Epub 2011 Dec 11.

PMID:
22160206
44.

In situ photopolymerization of biomaterials by thiol-yne click chemistry.

Lomba M, Oriol L, Alcalá R, Sánchez C, Moros M, Grazú V, Serrano JL, De la Fuente JM.

Macromol Biosci. 2011 Nov 10;11(11):1505-14. doi: 10.1002/mabi.201100123. Epub 2011 Jul 26.

PMID:
21793215
45.

Single instrument for hemostatic control in laparoscopic partial nephrectomy in a porcine model without renal vascular clamping.

Ríos JS, Zalabardo JM, Burdio F, Berjano E, Moros M, Gonzalez A, Navarro A, Güemes A.

J Endourol. 2011 Jun;25(6):1005-11. doi: 10.1089/end.2010.0557. Epub 2011 May 19.

PMID:
21595553
46.

Taking advantage of unspecific interactions to produce highly active magnetic nanoparticle-antibody conjugates.

Puertas S, Batalla P, Moros M, Polo E, Del Pino P, Guisan JM, Grazú V, de la Fuente JM.

ACS Nano. 2011 Jun 28;5(6):4521-8. doi: 10.1021/nn200019s. Epub 2011 May 5.

PMID:
21526783
47.

[Effects of an exercise training program on the quality of life of women with breast cancer on chemotherapy].

Moros MT, Ruidiaz M, Caballero A, Serrano E, Martínez V, Tres A.

Rev Med Chil. 2010 Jun;138(6):715-22. Spanish.

PMID:
20919481
48.

Engineering biofunctional magnetic nanoparticles for biotechnological applications.

Moros M, Pelaz B, López-Larrubia P, García-Martin ML, Grazú V, de la Fuente JM.

Nanoscale. 2010 Sep;2(9):1746-55. doi: 10.1039/c0nr00104j. Epub 2010 Jul 30.

PMID:
20676420
49.

Sterilization matters: consequences of different sterilization techniques on gold nanoparticles.

França A, Pelaz B, Moros M, Sánchez-Espinel C, Hernández A, Fernández-López C, Grazú V, de la Fuente JM, Pastoriza-Santos I, Liz-Marzán LM, González-Fernández A.

Small. 2010 Jan;6(1):89-95. doi: 10.1002/smll.200901006.

PMID:
19937607
50.

Septic shock in pregnancy due to pyogenic sacroiliitis: a case report.

Moros ML, Rodrigo C, Villacampa A, Ruiz J, Lapresta C.

J Med Case Rep. 2009 Mar 13;3:6505. doi: 10.1186/1752-1947-3-6505.

Supplemental Content

Support Center